Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ortho-hydroxybenzoic acid or derivative doai
Patent
1983-11-28
1985-01-29
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ortho-hydroxybenzoic acid or derivative doai
A61K 922, A61K 936, A61K 3160
Patent
active
044965532
ABSTRACT:
A pharmaceutical composition containing as active ingredient 5-aminosalicyclic acid or a pharmaceutically acceptable salt or ester thereof allow the treatment of colitis ulcerosa or Crohn's disease by oral administration. A particular slow-release tablet formation and its preparation is disclosed.
REFERENCES:
patent: 4190716 (1980-02-01), Parkinson et al.
patent: 4211777 (1980-07-01), Chambers
patent: 4298595 (1981-11-01), Parkinson et al.
Rasmussen et al., "Treatment of Crohn's Disease with Peroral 5-Aminosalicyclic Acid", Gastroenterology, 1983; 85:1350-1353.
Heatley et al., "Disodium Cromoglycate in the Treatment of Chromic Proctitis", Gut, 1975, 16, 559-563.
Mani et al., "Treatment of Ulcerative Colitis with Oral Disodium Cromoglycate", The Lancet, Feb. 28, 1976, pp. 439-441.
Dronfield et al., "Comparative Trial of Sulphasalazine and Oral Sodium Cromoglycate in the Maintenance of Remission in Ulcerative Colitis", Gut, 1978, 19, 1136-1139.
Buckell, "Controlled Trial of Disodium Cromoglycate in Chronic Persistent Ulcerative Colitis", Gut, 1978, 19, 1140-1143.
Willoughby et al., "Comparison of Disodium Cromoglycate and Sulphasalazine as Maintenance Therapy for Ulcerative Colitis", The Lancet, Jan. 20, 1979, pp. 119-122.
Pieniaszek, Jr. et al., Journal of Pharmaceutical Sciences, vol. 68, No. 10, Oct. 1979, pp. 1323-1325.
Goodman et al., "Ulcerative Colitis", Clinical Gastroenterology, 1978, pp. 3-16, 25, 73-74, 109-124, 128.
Kirsner, Jama, Feb. 8, 1980, vol. 243, No. 6.
Khan et al., "An Experiment to Determine the Active Therapeutic Moiety of Sulphasalazine", Lancet, 2, 1977, pp. 892-895.
Peppercorn et al., Gastroenterology 64, 1973, pp. 240-245.
Willoughby et al., Scand. J. Gastroent., 1980, 15, pp. 715-719.
Fischer et al., J. Chromatography, 162 (1979), pp. 237-243.
van Hees et al., Lancet, 1, 1978, p. 277.
van Hees et al., Gut, 1979, 20, pp. 300-304.
Schroeder et al., Clin. Pharm. and Ther., vol. 13, No. 4, 1972.
Klotz et al., New Engl. J. of Med., 303, No. 26, Dec. 1980.
Binder et al., "Disodium Cromoglycate in the Treatment of Ulcerative Colitis and Crohn's Disease", Gut, vol. 22, pp. 55-60, 1981.
Shafii et al., "Absorption, Enterohepatic Circulation, and Excretion of 5-Aminosalicyclic Acid in Rates, Gastroenterology, vol. 77, No. 5, 1982 pp. 297-299.
Farmaceutisk Laboratorium Ferring A/S
Rose Shep K.
LandOfFree
Pharmaceutical composition and method for the treatment of colit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition and method for the treatment of colit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition and method for the treatment of colit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-506170